U.S. Markets close in 26 mins

NanoVibronix, Inc. (NAOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6706+0.0057 (+0.86%)
As of 3:23PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6649
Open0.6504
Bid0.6705 x 800
Ask0.6820 x 1200
Day's Range0.6313 - 0.6899
52 Week Range0.5350 - 3.5000
Volume437,246
Avg. Volume4,022,595
Market Cap7.087M
Beta (5Y Monthly)-0.34
PE Ratio (TTM)N/A
EPS (TTM)-0.6150
Earnings DateJun 29, 2020 - Jun 30, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • NanoVibronix Expands Offerings with Introduction of PainShield Plus®
    Business Wire

    NanoVibronix Expands Offerings with Introduction of PainShield Plus®

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the launch of the next generation of its ultrasound pain management device, PainShield Plus® for the treatment of multiple areas of pain in tandem.

  • Business Wire

    NanoVibronix Receives Positive Nasdaq Listing Determination

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Company has received formal notification that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Capital Market pursuant to an extension through December 15, 2020, to evidence compliance with the minimum $2.5 million stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b) for continued listing on The Nasdaq Capital Market (the "Rule").

  • NanoVibronix Files U.S. Patent Application for PainShield® for Delivery of Cannabinoids for Alleviation of Chronic and Acute Pain
    PR Newswire

    NanoVibronix Files U.S. Patent Application for PainShield® for Delivery of Cannabinoids for Alleviation of Chronic and Acute Pain

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, announces its recent filing of a United States patent application entitled "A Transdermal Patch of a Portable Ultrasound-Generating System for Improved Delivery of Therapeutic Agents and Associated Methods of Treatment."